Lumbar Sympathetic Blockade in Children with Complex Regional Pain Syndromes A Double Blind Placebo-controlled Crossover Trial

被引:49
|
作者
Meier, Petra M. [1 ]
Zurakowski, David [1 ]
Berde, Charles B. [1 ]
Sethna, Navil F. [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA
关键词
INTRAVENOUS LIDOCAINE; STELLATE GANGLION; SENSORY THRESHOLDS; NEUROPATHIC PAIN; MAINTAINED PAIN; NERVOUS-SYSTEM; INJURY; HYPERALGESIA; DYSTROPHY; CAPSAICIN;
D O I
10.1097/ALN.0b013e3181aaea90
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Sympathetic blockade is used in the management of complex regional pain syndromes in children, but there are no data on the efficacy or mechanism(s) by which it produces pain relief. The purpose of this study is to compare the efficacy of lidocaine administered by lumbar sympathetic to IV route. Methods: Under general anesthesia, children with unilateral lower limb complex regional pain syndromes received catheters along the lumbar sympathetic chain. In a double-blind placebo-controlled crossover design, patients received IV lidocaine and lumbar sympathetic saline or lumbar sympathetic lidocaine and IV saline. Spontaneous and evoked pain ratings and sensory thresholds were assessed before and after these two lidocaine/saline doses and between routes of lumbar sympathetic blockade and IV. Results: Twenty-three patients, ages 10-18 yr, were enrolled. There was evidence for reduction of mean pain intensity of allodynia to brush (mean -1.4, 95% confidence interval [CI] -2.5 to -0.3) and to pinprick temporal summation (mean -1.3, 95% Cl -2.5 to -0.2) with lidocaine treatment via the lumbar sympathetic blockade compared to IV route. Lumbar sympathetic blockade also produced significant reduction in pain intensity compared to pretreatment values of allodynia to brush, pinprick and pinprick temporal summation and verbal pain scores. IV lidocaine did not produce significant changes in spontaneous and evoked pain intensity measurements compared to pretreatment values. There were no carryover effects as assessed by route-by-period interaction. Conclusions: Under the conditions of this study, the results provide some direct evidence that a component of pain may be mediated by abnormal sympathetic efferent activity.
引用
收藏
页码:372 / 380
页数:9
相关论文
共 50 条
  • [21] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF PROBUCOL IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    DURRINGTON, PN
    MILLER, JP
    ATHEROSCLEROSIS, 1985, 55 (02) : 187 - 194
  • [22] A DOUBLE-BLIND, CROSSOVER, PLACEBO-CONTROLLED TRIAL OF ADJUVANT NIFEDIPINE IN REFRACTORY EPILEPSY
    BRODIE, MJ
    LARKIN, JG
    COX, A
    BESAG, FM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (05) : P592 - P593
  • [23] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF INOSITOL TREATMENT FOR PANIC DISORDER
    BENJAMIN, J
    LEVINE, J
    FUX, M
    AVIV, A
    LEVY, D
    BELMAKER, RH
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (07): : 1084 - 1086
  • [24] Baclofen treatment in Tourette syndrome - A double-blind, placebo-controlled, crossover trial
    Singer, HS
    Wendlandt, J
    Krieger, M
    Giuliano, J
    NEUROLOGY, 2001, 56 (05) : 599 - 604
  • [25] Lamotrigine trial in idiopathic parkinsonism: A double-blind, placebo-controlled, crossover study
    Shinotoh, H
    Vingerhoets, FJG
    Lee, CS
    Uitti, RJ
    Schulzer, M
    Calne, DB
    Tsui, J
    NEUROLOGY, 1997, 48 (05) : 1282 - 1285
  • [26] A double-blind, placebo-controlled, crossover trial of riluzole in multiple system atrophy
    Wenning, G
    Seppi, K
    Diem, A
    Puschban, Z
    Mueller, J
    Poewe, W
    MOVEMENT DISORDERS, 2002, 17 : S40 - S40
  • [27] Suppression of tics with baclofen: Double-blind, placebo-controlled, crossover clinical trial
    Singer, HS
    Krieger, M
    Wendlandt, JT
    Guiliano, J
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 544 - 545
  • [28] Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism
    Lavigne, GJ
    Soucy, JP
    Lobbezoo, F
    Manzini, C
    Blanchet, PJ
    Montplaisir, JY
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 145 - 149
  • [29] Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial
    Giddens, Cheryl L.
    Barron, Kirk W.
    Clark, Keith F.
    Warde, William D.
    JOURNAL OF VOICE, 2010, 24 (04) : 477 - 489
  • [30] A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children
    Gawronska, A.
    Dziechciarz, P.
    Horvath, A.
    Szajewska, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (02) : 177 - 184